Structure and function of the CD7 molecule

被引:2
|
作者
Sempowski, GD
Lee, DM
Kaufman, RE
Haynes, BF
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Rheumatol Allergy & Clin Immunol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Hematol Oncol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA
关键词
T cells; NK cells; leukemia; septic shock;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD7 is a single-domain Ig superfamily molecule expressed on human T and NK cells, as well as on cells in the early stages of T, B, and myeloid cell differentiation. CD7 is highly expressed on malignant immature T cells and is generally absent on malignant mature T cells, such as CD4(+) Sezary leukemia and HTLV-1(+) adult T-cell leukemia cells. Because of lack of identification of a natural ligand and lack of a monoclonal antibody against murine CD7, the in vivo functions of CD7 have until recently remained obscure. Recent studies in CD7-deficient mice have provided new insights into CD7 function, and demonstrated key roles for CD7 in regulating peripheral T and NK cell cytokine production and sensitivity to LPS-induced shock syndromes. This article reviews recent work on the expression, structure, and function of CD7, and discusses roles the CD7 molecule might play in T and NK cell development and function.
引用
收藏
页码:331 / 348
页数:18
相关论文
共 50 条
  • [41] Evaluation of the convenience of the CD7 marker in the identification of Sezary cells
    Knol, AC
    Robillard, N
    Accard, F
    Chebassier, N
    Leroy, S
    Pandolfino, MC
    Guilloux, Y
    Jotereau, F
    Dréno, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (05) : 907 - 907
  • [42] DECREASED EXPRESSION OF CD7 OCCURS IN RHEUMATOID-ARTHRITIS
    LAZAROVITS, AI
    KARSH, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 72 (03): : 470 - 475
  • [43] CD28 costimulatory molecule - Expression, structure and function
    Bocko, D
    Kosmaczewska, A
    Ciszak, L
    Teodorowska, R
    Frydecka, I
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2002, 50 (03) : 169 - 177
  • [44] PRODUCTION AND CHARACTERIZATION OF THE EXTRACELLULAR DOMAIN OF HUMAN CD7 ANTIGEN
    OSSOWSKI, E
    ROY, A
    HOU, Z
    GARIEPY, B
    JUNG, LKL
    FASEB JOURNAL, 1994, 8 (05): : A780 - A780
  • [45] Intracellular retention of TCRαβ/CD3 and CD7 to generate novel allogeneic CAR-T cells targeting CD7 for treating T-cell malignancies
    Li, Jun
    Liu, Kaichun
    Fu, Jianmin
    Chen, Shanshan
    Zhang, Yinhang
    Xu, Guanggui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] CD7 CAR-T Therapy for Treating CD7-Positive Hematological Malignancies
    Lu, Peihua
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S74
  • [47] Evaluation of the convenience of the CD7 marker in the identification of Sezary cells
    Knol, AC
    Robillard, N
    Accard, F
    Chebassier, N
    Leroy, S
    Pandolfino, MC
    Guilloux, Y
    Jotereau, F
    Dréno, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) : 808 - 808
  • [48] CD7 CAR for the Treatment of Acute Myeloid and Lymphoid Leukemia
    Silva, Diogo
    Tashiro, Haruko
    Srinivasan, Madhuwanti
    Brenner, Malcolm K.
    Mamonkin, Maksim
    BLOOD, 2016, 128 (22)
  • [49] CD7 CAR-T: a bridge to transplant in AML
    Mamonkin, Maksim
    BLOOD, 2025, 145 (10) : 995 - 996
  • [50] Differential CD7 expression in acute leukaemia by flow cytometry
    Jain, P
    Morilla, R
    Owusu-Ankomah, K
    Rafiq, F
    Morilla, A
    Matutes, E
    Catovsky, D
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 68B (01) : 60 - 60